The global Microbial Fermentation Services for Biopharmaceuticals market size is predicted to grow from US$ 4024 million in 2025 to US$ 8362 million in 2031.
Key features:
- Process using microorganisms to convert raw materials into biologically active products.
- Products include antibiotics, vitamins, amino acids, enzyme preparations, hormones, vaccines, various cytokines, and monoclonal antibodies.
- Services provided by contract research organizations (CROs) or contract manufacturing organizations (CMOs).
Segmentation by Type:
- Bacteria
- Fungi
- Yeast
- Others
Segmentation by Application:
- Protein Drugs
- Vaccines
- Gene Therapy Vectors
- Other
Market by region:
- Americas
- APAC
- Europe
- Middle East & Africa
Company's coverage:
- Lonza
- BOC Sciences
- BioProduction by Sekisui
- KBI Biopharma
- FUJIFILM Diosynth Biotechnologies
- ADL Biopharma
- Nordmark Pharma GmbH
- AbbVie Contract Manufacturing
- Laurus Bio
- AGC Biologics
Key Questions Addressed in this Report:
Frequently Asked Questions
What is the USP of the report? expand_more
Microbial Fermentation Services for Biopharmaceuticals report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Microbial Fermentation Services for Biopharmaceuticals report is categorised based on following features:
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Microbial Fermentation Services for Biopharmaceuticals report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.